ANI Pharmaceuticals SG&A Expense (TTM) Insights

ANI Pharmaceuticals Inc (ANIP)

57.83 +1.04 (+1.83%) USD | NASDAQ | Oct 04, 16:00

57.88 +0.05 (+0.09%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2000. Upgrade now.

Date	Value
June 30, 2024	187.31M
March 31, 2024	173.25M
December 31, 2023	161.70M
September 30, 2023	150.42M
June 30, 2023	138.50M
March 31, 2023	131.70M
December 31, 2022	124.04M
September 30, 2022	121.56M
June 30, 2022	108.66M
March 31, 2022	95.52M
December 31, 2021	84.29M
September 30, 2021	67.95M
June 30, 2021	66.50M
March 31, 2021	68.89M
December 31, 2020	64.99M
September 30, 2020	64.64M
June 30, 2020	63.27M
March 31, 2020	56.24M
December 31, 2019	55.84M
September 30, 2019	55.20M
June 30, 2019	52.62M
March 31, 2019	48.39M
December 31, 2018	44.06M
September 30, 2018	39.57M
June 30, 2018	35.82M

Date	Value
March 31, 2018	33.24M
December 31, 2017	31.58M
September 30, 2017	30.06M
June 30, 2017	28.97M
March 31, 2017	29.22M
December 31, 2016	27.83M
September 30, 2016	25.92M
June 30, 2016	24.39M
March 31, 2016	22.31M
December 31, 2015	21.16M
September 30, 2015	20.44M
June 30, 2015	19.10M
March 31, 2015	18.98M
December 31, 2014	17.94M
September 30, 2014	16.62M
June 30, 2014	16.04M
March 31, 2014	17.78M
December 31, 2013	16.03M
September 30, 2013	15.50M
June 30, 2013	13.57M
March 31, 2013	8.347M
December 31, 2012	8.230M
September 30, 2012	7.051M
June 30, 2012	7.180M
March 31, 2012	7.220M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

55.84M

Minimum

Dec 2019

187.31M

Maximum

Jun 2024

104.49M

Average

95.52M

Median

Mar 2022

SG&A Expense (TTM) Benchmarks